Home Applications 212994 Application 212994
Type NDA
Sponsor COMMCAVE THERAPEUTICS SA Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 AZSTARYS SERDEXMETHYLPHENIDATE;DEXMETHYLPHENIDATE CAPSULE;ORAL 26.1MG/5.2MG Yes No 002 AZSTARYS SERDEXMETHYLPHENIDATE;DEXMETHYLPHENIDATE CAPSULE;ORAL 39.2MG/7.8MG Yes No 003 AZSTARYS SERDEXMETHYLPHENIDATE;DEXMETHYLPHENIDATE CAPSULE;ORAL 52.3MG/10.4MG Yes No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N212994-001 AZSTARYS DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE EQ 5.2MG BASE;EQ 26.1MG BASE CAPSULE / ORAL RLD 2021-05-07 N212994-002 AZSTARYS DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE EQ 7.8MG BASE;EQ 39.2MG BASE CAPSULE / ORAL RLD 2021-05-07 N212994-003 AZSTARYS DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE EQ 10.4MG BASE;EQ 52.3MG BASE CAPSULE / ORAL RLD, RS 2021-05-07
Orange Book patents# Current patent rows page 1 of 1 · 18 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N212994-001 9079928 2035-05-07 Drug product 2021-05-17 N212994-001 10584112 2037-12-09 Drug substance, Drug product 2021-05-17 N212994-001 10584113 2037-12-09 Drug product 2021-05-17 N212994-001 10759778 2037-12-09 Drug product 2021-05-17 N212994-001 10858341 2037-12-09 U-3094 2021-05-17 N212994-001 10954213 2037-12-09 U-3094 2021-05-17 N212994-002 9079928 2035-05-07 Drug product 2021-05-17 N212994-002 10584112 2037-12-09 Drug substance, Drug product 2021-05-17 N212994-002 10584113 2037-12-09 Drug product 2021-05-17 N212994-002 10759778 2037-12-09 Drug product 2021-05-17 N212994-002 10858341 2037-12-09 U-3094 2021-05-17 N212994-002 10954213 2037-12-09 U-3094 2021-05-17 N212994-003 9079928 2035-05-07 Drug product 2021-05-17 N212994-003 10584112 2037-12-09 Drug substance, Drug product 2021-05-17 N212994-003 10584113 2037-12-09 Drug product 2021-05-17 N212994-003 10759778 2037-12-09 Drug product 2021-05-17 N212994-003 10858341 2037-12-09 U-3094 2021-05-17 N212994-003 10954213 2037-12-09 U-3094 2021-05-17
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 3 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N212994-001 NCE 2026-05-07 N212994-002 NCE 2026-05-07 N212994-003 NCE 2026-05-07
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 2 of 3 · 111 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2024-10-29 15:01 UTC 2024-10 N212994-002 AZSTARYS EQ 7.8MG BASE;EQ 39.2MG BASE CAPSULE / ORAL RLD 2021-05-07 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N212994-003 AZSTARYS EQ 10.4MG BASE;EQ 52.3MG BASE CAPSULE / ORAL RLD, RS 2021-05-07 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N212994-001 AZSTARYS EQ 5.2MG BASE;EQ 26.1MG BASE CAPSULE / ORAL RLD 2021-05-07 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N212994-002 AZSTARYS EQ 7.8MG BASE;EQ 39.2MG BASE CAPSULE / ORAL RLD 2021-05-07 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N212994-003 AZSTARYS EQ 10.4MG BASE;EQ 52.3MG BASE CAPSULE / ORAL RLD, RS 2021-05-07 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N212994-001 AZSTARYS EQ 5.2MG BASE;EQ 26.1MG BASE CAPSULE / ORAL RLD 2021-05-07 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N212994-002 AZSTARYS EQ 7.8MG BASE;EQ 39.2MG BASE CAPSULE / ORAL RLD 2021-05-07 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N212994-003 AZSTARYS EQ 10.4MG BASE;EQ 52.3MG BASE CAPSULE / ORAL RLD, RS 2021-05-07 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N212994-001 AZSTARYS EQ 5.2MG BASE;EQ 26.1MG BASE CAPSULE / ORAL RLD 2021-05-07 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N212994-002 AZSTARYS EQ 7.8MG BASE;EQ 39.2MG BASE CAPSULE / ORAL RLD 2021-05-07 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N212994-003 AZSTARYS EQ 10.4MG BASE;EQ 52.3MG BASE CAPSULE / ORAL RLD, RS 2021-05-07 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N212994-001 AZSTARYS EQ 5.2MG BASE;EQ 26.1MG BASE CAPSULE / ORAL RLD 2021-05-07 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N212994-002 AZSTARYS EQ 7.8MG BASE;EQ 39.2MG BASE CAPSULE / ORAL RLD 2021-05-07 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N212994-003 AZSTARYS EQ 10.4MG BASE;EQ 52.3MG BASE CAPSULE / ORAL RLD, RS 2021-05-07 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N212994-001 AZSTARYS EQ 5.2MG BASE;EQ 26.1MG BASE CAPSULE / ORAL RLD 2021-05-07 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N212994-002 AZSTARYS EQ 7.8MG BASE;EQ 39.2MG BASE CAPSULE / ORAL RLD 2021-05-07 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N212994-003 AZSTARYS EQ 10.4MG BASE;EQ 52.3MG BASE CAPSULE / ORAL RLD, RS 2021-05-07 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N212994-001 AZSTARYS EQ 5.2MG BASE;EQ 26.1MG BASE CAPSULE / ORAL RLD 2021-05-07 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N212994-002 AZSTARYS EQ 7.8MG BASE;EQ 39.2MG BASE CAPSULE / ORAL RLD 2021-05-07 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N212994-003 AZSTARYS EQ 10.4MG BASE;EQ 52.3MG BASE CAPSULE / ORAL RLD, RS 2021-05-07 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N212994-001 AZSTARYS EQ 5.2MG BASE;EQ 26.1MG BASE CAPSULE / ORAL RLD 2021-05-07 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N212994-002 AZSTARYS EQ 7.8MG BASE;EQ 39.2MG BASE CAPSULE / ORAL RLD 2021-05-07 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N212994-003 AZSTARYS EQ 10.4MG BASE;EQ 52.3MG BASE CAPSULE / ORAL RLD, RS 2021-05-07 4b0b4de00fa7…2022-03-09 01:35 UTC 2022-03 N212994-001 AZSTARYS EQ 5.2MG BASE;EQ 26.1MG BASE CAPSULE / ORAL RLD 2021-05-07 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N212994-002 AZSTARYS EQ 7.8MG BASE;EQ 39.2MG BASE CAPSULE / ORAL RLD 2021-05-07 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N212994-003 AZSTARYS EQ 10.4MG BASE;EQ 52.3MG BASE CAPSULE / ORAL RLD, RS 2021-05-07 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N212994-001 AZSTARYS EQ 5.2MG BASE;EQ 26.1MG BASE CAPSULE / ORAL RLD 2021-05-07 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N212994-002 AZSTARYS EQ 7.8MG BASE;EQ 39.2MG BASE CAPSULE / ORAL RLD 2021-05-07 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N212994-003 AZSTARYS EQ 10.4MG BASE;EQ 52.3MG BASE CAPSULE / ORAL RLD, RS 2021-05-07 782e0a99824c…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N212994-001 AZSTARYS EQ 5.2MG BASE;EQ 26.1MG BASE CAPSULE / ORAL RLD 2021-05-07 6a51e52b5d6a…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N212994-002 AZSTARYS EQ 7.8MG BASE;EQ 39.2MG BASE CAPSULE / ORAL RLD 2021-05-07 6a51e52b5d6a…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N212994-003 AZSTARYS EQ 10.4MG BASE;EQ 52.3MG BASE CAPSULE / ORAL RLD, RS 2021-05-07 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N212994-001 AZSTARYS EQ 5.2MG BASE;EQ 26.1MG BASE CAPSULE / ORAL RLD 2021-05-07 1c564ffb4f44…2024-02-18 07:12 UTC 2024-02 N212994-002 AZSTARYS EQ 7.8MG BASE;EQ 39.2MG BASE CAPSULE / ORAL RLD 2021-05-07 1c564ffb4f44…2024-02-18 07:12 UTC 2024-02 N212994-003 AZSTARYS EQ 10.4MG BASE;EQ 52.3MG BASE CAPSULE / ORAL RLD, RS 2021-05-07 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N212994-001 AZSTARYS EQ 5.2MG BASE;EQ 26.1MG BASE CAPSULE / ORAL RLD 2021-05-07 ea1830bbd6c7…2023-12-20 04:57 UTC 2023-12 N212994-002 AZSTARYS EQ 7.8MG BASE;EQ 39.2MG BASE CAPSULE / ORAL RLD 2021-05-07 ea1830bbd6c7…2023-12-20 04:57 UTC 2023-12 N212994-003 AZSTARYS EQ 10.4MG BASE;EQ 52.3MG BASE CAPSULE / ORAL RLD, RS 2021-05-07 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N212994-001 AZSTARYS EQ 5.2MG BASE;EQ 26.1MG BASE CAPSULE / ORAL RLD 2021-05-07 a72a2bbeb626…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N212994-002 AZSTARYS EQ 7.8MG BASE;EQ 39.2MG BASE CAPSULE / ORAL RLD 2021-05-07 a72a2bbeb626…
Observed Orange Book patent history# Patent history page 1 of 17 · 666 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-11-14 07:37:17 2026-10 N212994-001 9079928 2035-05-07 Drug product 2021-05-17 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N212994-001 10584112 2037-12-09 Drug substance, Drug product 2021-05-17 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N212994-001 10584113 2037-12-09 Drug product 2021-05-17 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N212994-001 10759778 2037-12-09 Drug product 2021-05-17 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N212994-001 10858341 2037-12-09 U-3094 2021-05-17 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N212994-001 10954213 2037-12-09 U-3094 2021-05-17 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N212994-002 9079928 2035-05-07 Drug product 2021-05-17 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N212994-002 10584112 2037-12-09 Drug substance, Drug product 2021-05-17 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N212994-002 10584113 2037-12-09 Drug product 2021-05-17 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N212994-002 10759778 2037-12-09 Drug product 2021-05-17 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N212994-002 10858341 2037-12-09 U-3094 2021-05-17 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N212994-002 10954213 2037-12-09 U-3094 2021-05-17 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N212994-003 9079928 2035-05-07 Drug product 2021-05-17 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N212994-003 10584112 2037-12-09 Drug substance, Drug product 2021-05-17 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N212994-003 10584113 2037-12-09 Drug product 2021-05-17 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N212994-003 10759778 2037-12-09 Drug product 2021-05-17 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N212994-003 10858341 2037-12-09 U-3094 2021-05-17 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N212994-003 10954213 2037-12-09 U-3094 2021-05-17 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N212994-001 9079928 2035-05-07 Drug product 2021-05-17 c2088c7a36db…2026-10-15 13:18:30 2026-09 N212994-001 10584112 2037-12-09 Drug substance, Drug product 2021-05-17 c2088c7a36db…2026-10-15 13:18:30 2026-09 N212994-001 10584113 2037-12-09 Drug product 2021-05-17 c2088c7a36db…2026-10-15 13:18:30 2026-09 N212994-001 10759778 2037-12-09 Drug product 2021-05-17 c2088c7a36db…2026-10-15 13:18:30 2026-09 N212994-001 10858341 2037-12-09 U-3094 2021-05-17 c2088c7a36db…2026-10-15 13:18:30 2026-09 N212994-001 10954213 2037-12-09 U-3094 2021-05-17 c2088c7a36db…2026-10-15 13:18:30 2026-09 N212994-002 9079928 2035-05-07 Drug product 2021-05-17 c2088c7a36db…2026-10-15 13:18:30 2026-09 N212994-002 10584112 2037-12-09 Drug substance, Drug product 2021-05-17 c2088c7a36db…2026-10-15 13:18:30 2026-09 N212994-002 10584113 2037-12-09 Drug product 2021-05-17 c2088c7a36db…2026-10-15 13:18:30 2026-09 N212994-002 10759778 2037-12-09 Drug product 2021-05-17 c2088c7a36db…2026-10-15 13:18:30 2026-09 N212994-002 10858341 2037-12-09 U-3094 2021-05-17 c2088c7a36db…2026-10-15 13:18:30 2026-09 N212994-002 10954213 2037-12-09 U-3094 2021-05-17 c2088c7a36db…2026-10-15 13:18:30 2026-09 N212994-003 9079928 2035-05-07 Drug product 2021-05-17 c2088c7a36db…2026-10-15 13:18:30 2026-09 N212994-003 10584112 2037-12-09 Drug substance, Drug product 2021-05-17 c2088c7a36db…2026-10-15 13:18:30 2026-09 N212994-003 10584113 2037-12-09 Drug product 2021-05-17 c2088c7a36db…2026-10-15 13:18:30 2026-09 N212994-003 10759778 2037-12-09 Drug product 2021-05-17 c2088c7a36db…2026-10-15 13:18:30 2026-09 N212994-003 10858341 2037-12-09 U-3094 2021-05-17 c2088c7a36db…2026-10-15 13:18:30 2026-09 N212994-003 10954213 2037-12-09 U-3094 2021-05-17 c2088c7a36db…2026-09-14 22:38:34 2026-08 N212994-001 9079928 2035-05-07 Drug product 2021-05-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212994-001 10584112 2037-12-09 Drug substance, Drug product 2021-05-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212994-001 10584113 2037-12-09 Drug product 2021-05-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212994-001 10759778 2037-12-09 Drug product 2021-05-17 84e616aacf4f…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 3 · 111 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 15 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 65038-286 AZSTARYS Serdexmethylphenidate and Dexmethylphenidate Corium, Inc NDA Current 65038-286 AZSTARYS Serdexmethylphenidate and Dexmethylphenidate Corium, Inc NDA Current 65038-286 AZSTARYS Serdexmethylphenidate and Dexmethylphenidate Corium, Inc NDA Current 65038-286 AZSTARYS Serdexmethylphenidate and Dexmethylphenidate Corium, Inc NDA Current 65038-286 AZSTARYS Serdexmethylphenidate and Dexmethylphenidate Corium, Inc NDA Current 65038-429 AZSTARYS Serdexmethylphenidate and Dexmethylphenidate Corium, Inc NDA Current 65038-429 AZSTARYS Serdexmethylphenidate and Dexmethylphenidate Corium, Inc NDA Current 65038-429 AZSTARYS Serdexmethylphenidate and Dexmethylphenidate Corium, Inc NDA Current 65038-429 AZSTARYS Serdexmethylphenidate and Dexmethylphenidate Corium, Inc NDA Current 65038-429 AZSTARYS Serdexmethylphenidate and Dexmethylphenidate Corium, Inc NDA Current 65038-561 AZSTARYS Serdexmethylphenidate and Dexmethylphenidate Corium, Inc NDA Current 65038-561 AZSTARYS Serdexmethylphenidate and Dexmethylphenidate Corium, Inc NDA Current 65038-561 AZSTARYS Serdexmethylphenidate and Dexmethylphenidate Corium, Inc NDA Current 65038-561 AZSTARYS Serdexmethylphenidate and Dexmethylphenidate Corium, Inc NDA Current 65038-561 AZSTARYS Serdexmethylphenidate and Dexmethylphenidate Corium, Inc NDA Current
Documents# Document, Submission type, Date table Document Submission type Date 83506 SUPPL 2025-09-25 83505 SUPPL 2025-09-25 83464 SUPPL 2025-09-25 75890 SUPPL 2023-10-23 75891 SUPPL 2023-10-17 75859 SUPPL 2023-10-17 75827 SUPPL 2023-10-17 68936 ORIG 2021-10-08 66937 ORIG 2021-04-01 66497 ORIG 2021-03-04 66495 ORIG 2021-03-04 66493 ORIG 2021-03-04